Ex Parte VAN ASSCHE et al - Page 2


                Appeal No. 1997-4272                                                                          
                Application No. 08/429,053                                                                    

                      23.    A hybridoma cell line prepared by extracting maize plants at low                 
                             temperature by grinding, centrifuging and filtration, enriching the              
                             extract in protein by precipitation with polyethylene glycol,                    
                             recovering the precipitate by centrifugation, dissolving the                     
                             precipitate in a buffer solution and recovering monoclonal                       
                             hybridomas of claim 11 from the antigen solution.                                
                      24.    A monoclonal antibody directed specifically against proteins having              
                             saccharose phosphate synthetase (SPS) activity of Sequence ID                    
                             #11 or Sequence ID #12.                                                          

                      The examiner relies on the following references:                                        
                      Kalt-Torres et al. (Kalt-Torres), “Isolation and Characterization of Multiple           
                      Forms of Maize Leaf Sucrose-Phosphate Synthase,” Physiol. Plantarum,                    
                      Vol. 70, pp. 653-658 (1987)                                                             
                      Walker et al. (Walker), “Purification and Preliminary Characterization of               
                      Sucrose-Phosphate Synthase using Monoclonal Antibodies,” Plant.                         
                      Physiol., Vol. 89, pp. 518-524 (1989)                                                   
                      Claim 23 stands rejected under 35 U.S.C. § 112, second paragraph, as                    
                indefinite.                                                                                   
                      Claims 11, 23, and 24 stand rejected under 35 U.S.C. § 103 as obvious                   
                over the combined disclosures of Walker and Kalt-Torres.                                      
                      We affirm the rejection under 35 U.S.C. § 112, second paragraph.  We                    
                reverse in part and vacate in part the rejection under 35 U.S.C. § 103.  We also              
                enter a new ground of rejection.                                                              
                                                 Discussion                                                   
                      The claims are directed to specific hybridoma cell lines (claim 11),                    
                hybridoma cell lines produced by a defined process (claim 23), and monoclonal                 
                antibodies that bind a saccharose phosphate synthetase (SPS) enzyme (claim                    



                                                      2                                                       



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007